GigaCloud Technology Q2 Net Income Declines; Total Revenues Up 11.0%

GigaCloud Technology Inc (GCT) reported that its second quarter net income declined to $6.1 million from $13.6 million, prior year. Earnings per share was $0.15, compared to $0.43.

Total revenues were $124.0 million, an increase of 11.0% from $111.8 million, a year ago. The company said the increase was primarily due to an increase in service revenue from GigaCloud 3P and product revenue from GigaCloud 1P, partially offset by the decrease in product revenue from off-platform ecommerce.

David Lau, CFO of GigaCloud, said, "We are pleased to see topline growth despite a quarter of supply chain challenges. This is attributable to the company's effort to continue attracting more buyers and sellers as demand continues to rise for large parcel sales and deliveries."

The company expects total revenues to be between $122 million and $127 million in the third quarter of 2022.

Shares of GigaCloud Technology are up 8% in pre-market trade on Friday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Health insurer Humana Inc. reported Wednesday a net loss for the fourth quarter that slightly widened from last year, hurt primarily by charges associated with productivity initiatives, despite 6.6 percent revenue growth. Adjusted earnings for the quarter topped analysts' expectations, while quarterly revenues missed it by a whisker. South Plainfield, New Jersey-based Two Rivers Coffee is recalling its peanut butter single serve hot chocolate pods citing an undeclared peanut allergen, the U.S. Food Drug Administration said. The recall involves peanut butter single serve hot chocolate pods distributed as "Brooklyn Bean Peanut Butter Cup Hot Cocoa", "Pingo Peanut Butter Cookie Hot Chocolate" and ... Shares of Novartis AG were losing around 2 percent in the early morning trading in Switzerland after the drug major reported Wednesday sharply lower profit in its fourth quarter with weak sales as well as the absence of prior year's hefty Roche income. Adjusted earnings, however, topped market estimates, while top line missed their view. Further, the company announced higher dividend...
Follow RTT